Medical Affairs Director and Cannabinoid Researcher
Specialty: Family Medicine
Dr Ashleigh Osborne (BMHlthSc, Hons I, PhD) is an experienced Medical Affairs professional and cannabinoid researcher who serves as Medical & Research Director for Medigrowth Australia. She also holds an Affiliate Lecturer position in the Research & Innovation Portfolio at Deakin University. Ashleigh has been in the cannabinoid field since 2013 – before medicinal cannabis was legalised in Australia – and brings over 13 years of expertise, including a PhD focused on the therapeutic potential of CBD and was awarded Examiners Commendation for Outstanding Thesis. Ashleigh’s scientific contributions are well-recognised with her cannabinoid research published in several high impact, peer-reviewed international journals, accumulating almost 600 citations to date. She has presented at numerous national and international scientific conferences, and her work has been supported by grants from government, universities, and non-profit organisations. With a strong focus on cannabinoid science, Ashleigh’s work in the pharmaceutical and medical device industries over the last 7 years of experience has given her expertise across a range of therapeutic areas, including psychiatry, rheumatology, neurology, dermatology, gastroenterology, oncology, women’s health, and addiction medicine. She has educated thousands of healthcare professionals in quality use of medicines and medical vaporisers to transform patient care. Ashleigh is deeply passionate about improving outcomes for patients, empowering healthcare professionals, and driving medical education and research to advance cannabinoid-based medicine.